| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 394709-83-2 | Methyl Piperazine-2-Acetate Dihydrochloride | C7H16N2O2 |
| 394722-29-3 | 250-258-Cleavage and polyadenylation specificity factor (human) | C53H83N13O11 |
| 394722-46-4 | L-Leucyl-L-methionyl-L-leucyl-L-glutaminyl-L-asparaginyl-L-alanyl-L-leucyl-L-threonyl-L-threonyl-L-methionine | C48H86N12O15S2 |
| 394729-17-0 | 4-[6-Amino-5-Bromo-2-[(4-Cyanophenyl)Amino]Pyrimidin-4-Yl]Oxy-3,5-Dimethylbenzonitrile | C20H15BrN6O |
| 394729-98-7 | 2-Chloro-4-methoxynicotinic acid | C7H6ClNO3 |
| 394730-60-0 | Boceprevir | C27H45N5O5 |
| 394734-77-1 | (2S,4S)-Boc-4-Cyclohexyl-Pyrrolidine-2-Carboxylic Acid | C16H27NO4 |
| 394735-17-2 | Ethyl 2-amino-3-cyclobutylpropanoate | C9H17NO2 |
| 394735-18-3 | N-[1-(Cyclobutylmethyl)-2-(methoxymethylamino)-2-oxoethyl]-carbamic Acid 1,1-Dimethylethyl Ester | C14H26N2O4 |
| 394735-20-7 | N-[2-Cyano-1-(cyclobutylmethyl)-2-hydroxyethyl]-carbamic Acid 1,1-Dimethylethyl Ester | C13H22N2O3 |
| 394735-22-9 | tert-Butyl 4-amino-1-cyclobutyl-3,4-dioxobutan-2-ylcarbamate | C13H24N2O4 |
| 394735-23-0 | beta-Amino-alpha-hydroxycyclobutanebutanamide hydrochloride | C8H16N2O2.HCl |
| 394735-26-3 | (1R,2S,5S)-3-[(2S)-2-[[(1,1-Dimethylethoxy)carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid methyl ester | C20H34N2O5 |
| 394735-27-4 | (1R,2S,5S)-3-[(2S)-2-[[[(1,1-Dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid methyl ester | C20H35N3O4 |
| 394735-28-5 | (1R,2S,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2-hydroxy-3-oxopropyl]-3-[(2S)-2-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide | C27H47N5O5 |
| 394735-65-0 | (S)-2-((tert-Butoxycarbonyl)amino)-2-(4,4-difluorocyclohexyl)acetic acid | C13H21F2NO4 |
| 395058-87-4 | 3-(2-Hydroxyethyl)-2-Methyl-1,3-Oxazolidin-2-Ol | C6H13NO3 |
| 395058-89-6 | 3-(2-Hydroxyethyl)-2-(Methylamino)-1,3-Oxazolidin-2-Ol | C6H14N2O3 |
| 395058-91-0 | L-Tyrosyl-L-leucyl-L-valyl-L-prolyl-L-glutaminyl-L-glutaminylglycyl-L-phenylalanyl-L-phenylalanyl-L-cysteine | C58H80N12O14S |
| 395059-21-9 | 2,5-Dibromo-1,4-benzenedimethanol | C8H8Br2O2 |
| 395063-57-7 | 2-Methyl[1,3]Thiazolo[3,2-b][1,2,4]Triazol-6(5H)-One | C5H5N3OS |
| 395065-72-2 | N-(4-Methyl-1,3-Benzothiazol-2-Yl)Ethanimidamide | C10H11N3S |
| 395065-74-4 | N-(6-Methyl-1,3-Benzothiazol-2-Yl)Acetamidine | C10H11N3S |
| 395065-75-5 | N-(4,6-Dimethyl-1,3-Benzothiazol-2-Yl)Ethanimidamide | C11H13N3S |
| 395067-35-3 | 2-(2-Aminoethyl)-2H-Tetrazol-5-Amine | C3H8N6 |
| 395069-92-8 | Glycyl-L-alanyl-L-leucyl-L-phenylalanyl-L-leucylglycyl-L-phenylalanyl-L-leucylglycyl-L-alanyl-L-alanylglycyl-L-seryl-L-threonyl-L-methionylglycyl-L-alanyl-L-tryptophyl-L-seryl-L-glutaminyl-L-prolyl-L-lysyl-L-seryl-L-lysyl-L-arginyl-L-lysyl-L-valine | C126H201N35O33S |
| 395069-95-1 | L-Methionylglycyl-L-leucylglycyl-L-leucyl-L-histidyl-L-leucyl-L-leucyl-L-valyl-L-leucyl-L-alanyl-L-alanyl-L-alanyl-L-leucyl-L-glutaminylglycyl-L-alanyl-L-tryptophyl-L-seryl-L-glutaminyl-L-prolyl-L-lysyl-L-lysyl-L-lysyl-L-arginyl-L-lysyl-L-valine | C134H229N39O31S |
| 395071-78-0 | 3,10-Diazatricyclo[5.3.1.03,8]Undeca-1(11),5,7,9-Tetraene | C9H8N2 |
| 395074-91-6 | cis-3-Phenylcyclobutanamine | C10H13N |
| 395082-71-0 | Methyl (1R,2S,4S)-Bicyclo[2.2.1]Heptane-2-Carboximidate | C9H15NO |
| 395082-72-1 | Methyl (1R,2R,4S)-Bicyclo[2.2.1]Heptane-2-Carboximidate | C9H15NO |
| 395083-12-2 | 1-(5-Vinyl-2-Thienyl)Ethanone | C8H8OS |
| 395083-14-4 | Potassium isopropenyltrifluoroborate | C3H5BF3.K |
| 395087-89-5 | (3-Dibenzofuranyl)boronic acid | C12H9BO3 |
| 395090-68-3 | 3-Methyl-3-(1H-Pyrrol-1-Yl)Butanoicacid | C9H13NO2 |
| 395099-05-5 | 5-Amino-3-phenyl-1H-indazole | C13H11N3 |
| 395100-09-1 | 3-(4-Fluorophenyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole-5-carbonitrile | C19H16FN3O |
| 395100-11-5 | 4-Fluoro-3-(4-fluorobenzoyl)benzonitrile | C14H7F2NO |
| 395100-12-6 | 3-(4-Fluorophenyl)-1H-indazole-5-carbonitrile | C14H8FN3 |
| 395101-67-4 | 3-Bromo-5-Cyano (1H)Indazole | C8H4BrN3 |
| 395103-65-8 | 3-[4-[2-(Morpholin-4-yl)ethoxy]phenyl]-1H-indazole-5-carbonitrile | C20H20N4O2 |
| 395104-30-0 | 3-[3-[2-(1-Piperidinyl)ethoxy]phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole | C22H24N6O |
| 395116-70-8 | Di(1-adamantyl)benzylphosphine | C27H37P |
| 395639-32-4 | (2E)-2-(2,4-Dihydroxybenzylidene)-N-Hydroxyhydrazinecarboxamide | C8H9N3O4 |
| 395639-53-9 | Aselizumab | |
| 395643-30-8 | 4-Methyl-3,6-Dioxo-1,4-Cyclohexadiene-1-Carbaldehyde | C8H6O3 |
| 395643-31-9 | 5-Methyl-3,6-Dioxo-1,4-Cyclohexadiene-1-Carbaldehyde | C8H6O3 |
| 395645-41-7 | 4-Formylnicotinic Acid | C7H5NO3 |
| 395652-44-5 | 4-(2-Pyridinyl)-3-Butyn-1-Ol | C9H9NO |
| 395653-63-1 | 5-Cyclopropyl-1H-Pyrazole-3-Carbohydrazide | C7H10N4O |